中國的醫療改革與IVD，醫療設備，對醫藥品市場的影響

中國急速的經濟發展以及1997年以後中央政府的許多改革，對該國國內醫療服務市場與醫藥品，醫療設備，體外診斷(IVD)市場產生很大的影響。

本報告提供中國的醫療制度的概要與制度改革的背景，IVD產品，醫療設備，醫藥品市場趨勢，各地區分析彙整，為您概述為以下內容。

第1章 摘要整理

第2章 簡介與主要的指標和改革的需求

• 簡介
• 醫療輔助員和Rural Cooperative Medical Scheme
• 中國的經濟改革對醫療的影響
• Rural Cooperative Medical Scheme與政府改革的再承諾
• 醫療改革

第3章 中國的醫療市場改革與所形成的地方，城市，地區，省的市場

• 簡介
• 2009∼2011年的醫療改革
• 基層層級的醫療改革
• 海外醫療產品供應商滲透中國市場

第4章 中國的診斷藥:到2015年的市場的機會與課題

• 簡介
• 中國IVD市場上需求面促進因素
  • 糖尿病
  • 癌症
  • 過敏
  • 感染病
• 醫療制度/改革的供應方面的促進因素
  • 診療部門實驗室
  • 自我檢驗
  • 醫院·民間檢驗所
  • 研究·技術部門
• 市場規模與預測
• 市場分佈與產業趨勢
  • 中國國內的IVD產業
• 相關法規

第5章 中國的醫療設備:到2015年的市場的機會與課題

• 簡介
• 中國醫療設備市場需求面促進因素
  • 癌症
  • 心血管疾病
  • 高齡化
• 醫療制度/改革:供應方面的促進因素
  • 醫院
  • 特殊治療診所
  • 公共診所，健康中心，"基層"醫療機關
• 市場規模與預測
• 市場分佈與產業趨勢
  • 中國國內的IVD產業
• 相關法規
  • 製造企業的認證
  • 醫療程序和和報銷的費用削減
  • 設備認證

第6章 中國的醫藥品:到2015年的市場的機會與課題

• 簡介
• 中國醫藥品市場上需求面促進因素
  • 糖尿病
  • 高血壓·心臟病
  • 癌症
  • 感染病
  • 自我醫療
• 供應方面的促進因素與市場流通管道
  • 院內藥物部
  • 零售藥局
  • 其他的商業流通管道:量販店，郵購，線上
• 市場規模與預測
• 市場分佈與產業趨勢
  • "大製藥公司"
  • 中國國內的醫藥品產業
• 相關法規
  • 製造企業的認證
  • 製造商層級的藥價管理
  • 藥局等級的藥價管理
  • 藥物核准
  • 智慧財產權保護

第7章 結論

圖表

China's rapid economic development and the numerous steps of reform undertaken by the Chinese central government since 1997 have had clear and observable effects upon China's total healthcare services market and its product markets for pharmaceuticals, medical devices, and in vitro diagnostics (IVD). This progress has been augmented by a Reform program in 2009, which includes increased funding to improve services.

What are the workings of China's healthcare system? How much progress has been made towards the promised vision of the CPCC in 2008 to provide “convenient and affordable access” to its people? What are the effects on foreign companies seeking to benefit from an increase in healthcare-related funding? Where are the best opportunities in China for marketers? Kalorama analyst Emil Salazar focuses on these questions and more.

The report contains a comprehensive overview of the Chinese healthcare system with important data for marketers to China. It discusses healthcare reform plans and where funds were spent. It also describes the role foreign companies play.

As part of its analysis, the report includes the following information:

• Statistics on Chinese Hospitals, Community Health Centers and Clinics
• Top and Bottom City Markets for Urban Healthcare
• Top and Bottom Rural Regions
• Challenges for Foreign-Owned MNCs in China
• Government Healthcare Spending
• Foreign-Invested Manufacturing Enterprises in China
• Share of Government Funded Healthcare vs. Out of Pocket
• Domestic Healthcare Industries
• Population and Age Statistics
• Incidence Rates for Infectious Diseases
• Cancer Rates in China
• Regulation of Drugs and Devices in China
• U.S. Product Exports to China
• Key Analyst Conclusions

In addition to providing useful background information and a thorough analysis of China's healthcare changes, the report provides data for business planning.

It also takes a look at the status and forecast of the three key healthcare markets in China:

• The Chinese Market for IVD products
• Regional Breakout of the Chinese IVD Market (Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern)
• The Chinese Market for Medical Device Products
• Regional Breakout of the Chinese Medical Device Market (Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern)
• Segment Breakout of the Chinese Medical Device Market (Surgical Instrument, Disposable, Patient Monitoring, IVD, Imaging, Orthopedic, Other)
• The Chinese Market for Pharmaceutical Products
• Regional Breakout of the Pharmaceutical Market (Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern)
• Segment Breakout of the Pharmaceutical Market (Cardiovascular, Gastrointestinal, Anti-Infectives, Neurotherapeutics, Oncology, Respiratory, Other)

This essential resource for anyone marketing a healthcare product to China was constructed using a combination of primary and secondary sources. Corporate reports, trade publications government information and medical journals, previous market research studies conducted by Kalorama and other sources were used. In some cases, interviews were used to determine forecasts and key trends.

CHAPTER ONE: EXECUTIVE SUMMARY

• Healthcare in China
• Healthcare Reform and Market Impact
  • Rural Healthcare Market in Era of Reform
  • Urban Healthcare Market in Era of Reform
  • China's IVD Market in an Era of Reform
  • China's Medical Devices Market in an Era of Reform
  • China's Pharmaceuticals Market in an Era of Reform
• Major Findings

CHAPTER TWO: HEALTHCARE IN CHINA - PRIMARY INDICATORS AND A NEED FOR REFORM

• Introduction
• Barefoot Doctors and the Rural Cooperative Medical Scheme (RCMS)
• China's Economic Reform Impacts Healthcare
• New Rural Cooperative Medical Scheme (NRCMS) and Government Recommitment to Reform
• China on the Eve of Contemporary Healthcare Reform

CHAPTER THREE: CHINA'S “REFORM” HEALTHCARE MARKET AND ITS SHAPING OF RURAL, URBAN, REGIONAL AND PROVINCIAL MARKETS

• Introduction
• China's 2009-2011 Healthcare Reform in Its Main Features and Provisions
• Healthcare Reform on the “Grassroots” Level - The Many Chinas in Focus
  • The Contemporary Rural Healthcare Market in China - Major Regions, Institutions and Landscape
  • Rural China Healthcare Market from the NRCMS to the End of Healthcare Reform under the 12th Five-Year Plan (2004-2015) - Historical and Projected Market Sizes and Segmentation
  • Urban Healthcare Markets in China and their Trajectory through Reform (2004-2015)
• Foreign Medical Product Suppliers Penetrate the Chinese Market

CHAPTER FOUR: DIAGNOSTICS IN CHINA - MARKET OPPORTUNITIES AND CHALLENGES THROUGH 2015

• Introduction
• Demand-Side Drivers in the Chinese IVD Market
  • Diabetes
  • Cancer
  • Allergy
  • Infectious Disease
• Healthcare System/ Reform Supply-Side Drivers
  • Physician Office Laboratories (POL
  • Self-Testing
  • Hospital and Private Laboratories
  • Research and Technology Sector
• Market Size and Projections
• Market Distribution and The State of The Industry
  • Domestic Chinese IVD Industry
• Regulation

CHAPTER FIVE: MEDICAL DEVICES IN CHINA - MARKET OPPORTUNITIES AND CHALLENGES THROUGH 2015

• Introduction
• Demand-Side Drivers in the Chinese Medical Device Market
  • Cancer
  • Cardiovascular Diseases
  • Aging
• Healthcare System/Reform - Supply-Side Drivers
  • Hospitals
  • Specialty Treatment Clinics
  • Public Clinics, Health Centers and “Grass Roots” Medical Institutions
• Market Size and Projections
• Market Distribution and the State of the Industry
  • Foreign Manufacturers
  • Domestic Chinese IVD Industry
• Regulation
  • Manufacturing Enterprise Approvals
  • Cost Controls for Medical Procedures and Reimbursements
  • Device Approval

CHAPTER SIX: PHARMACEUTICALS IN CHINA - MARKET OPPORTUNITIES AND CHALLENGES THROUGH 2015

• Introduction
• Demand-Side Drivers in the Chinese Pharmaceuticals Market
  • Diabetes
  • Hypertension and Heart Disease
  • Cancer
  • Infectious Diseases
  • Self-Medication
• Supply-Side Drivers (Healthcare Reform) and Market Channels
  • Hospital Pharmacies
  • Retail Pharmacies
  • Other Commercial Channels - Mass Merchants, Mail Order and Online
• Market Size and Projections

MARKET DISTRIBUTION AND THE STATE OF THE INDUSTRY

• “Big Pharma” - western MNCs in China
• Domestic Chinese Pharma Industry

REGULATION

• Manufacturing Enterprise Approvals
• Pricing Controls at Manfacturer-Level
• Pricing Controls at Pharmacy-Level
• Drug Approval
• Intellectual Property Protection (IPP)

CHAPTER SEVEN: CONCLUSIONS

• Conclusion One
• Conclusion Two
• Conclusion Three
• Conclusion Four
• Conclusion Five
• Conclusion Six
• Conclusion Seven

CHAPTER ONE: EXECUTIVE SUMMARY

• Table 1-1: Government-Run Urban Health Insurance Programs in China
• Figure 1-1: Chinese Healthcare Reform Government Funding Breakdown (2009-2011)
• Figure 1-2: Rural and Urban China Healthcare Market (Insurance and Out-of-Pocket Payments) (2004-2015) (billion yuan)
• Figure 1-3: IVD, Pharmaceuticals and Medical Devices Markets in China (2004-2015) (billions $)

CHAPTER TWO: HEALTHCARE IN CHINA - PRIMARY INDICATORS AND A NEED FOR REFORM

• Figure 2-1: Chinese National Population (% Urban/Rural)
• Figure 2-2: Chinese Government Health Expenditures (in billion yuan and % of total health expenditures) (1980-2009)
• Figure 2-3: Average Inpatient Visit Costs and Bed Utilization at Chinese Public Hospitals (1985-2010)
• Figure 2-4: Gross National Income (GNI) Per Capita - China and OECD Member Country Average (1980-2009)
• Figure 2-5: Chinese Bureaucratic and Market Divisions (East, Middle, West China)
• Figure 2-6: Private Hospitals in China by Region (East / Middle / West) (2010)
• Figure 2-7: Number of Private and Public Hospitals in China (1980-2010)
• Figure 2-8: Income Sources for Government-Run Hospitals (%)
• Figure 2-9: New Rural Cooperative Medical Scheme Enrollment (2004-2010)
• Table 2-1: Government-Run Urban Health Insurance Programs in China
• Figure 2-10: Government Health Insurance Coverage (2003 and 2008)
• Figure 2-11: Hospital Visits in China (millions) (1995-2010)
• Table 2-2: Government Healthcare Expenditure and GDP Growth Rates (China and Selected Comparison Countries; 2000-2008
• Figure 2-12: Chinese Population by Age (Total; 1990/2000/2009) (%)

CHAPTER THREE: CHINA'S “REFORM” HEALTHCARE MARKET AND ITS SHAPING OF RURAL, URBAN, REGIONAL AND PROVINCIAL MARKETS

• Figure 3-1: Chinese Healthcare Reform Government Funding Breakdown (2009-2011)
• Figure 3-2: Chinese Rural Healthcare Market by National Market Shares of Province/Direct-Controlled Municipality (2010)
  • Rural China Healthcare Market (Total Consumer/Out-of-Pocket/Insurance Expenditures) (2004-2010) (billion yuan)
• Table 3-1: Rural China Healthcare Market (Total Consumer/Out-of-Pocket/Insurance Expenditures) (2004-2010) (billion yuan)
• Figure 3-4: Regional Shares of Reimbursement Funds under NRCMS (2010) (East/Middle/West China) (%)
• Figure 3-5: Rural China Healthcare Market (Total Consumer/Out-of-Pocket/Insurance Expenditures) (2010-2015 Projection) (billion yuan)
• Table 3-2: Rural China Healthcare Market (Total Consumer/Out-of-Pocket/Insurance Expenditures) (2010-2015 Projection) (billion yuan)
• Table 3-3: Top and Bottom Five Provincial Markets for Rural Healthcare by Gain and Loss in National Market Share (2010-2015)
• Figure 3-6: Chinese Urban Healthcare Market by National Market Shares of Province/Direct-Controlled Municipality (2010)
• Figure 3-7: Outpatient Visits in the Urban Healthcare Market, 2010 (Hospitals, Community Health Centers, Community Health Stations, Clinics, Other) (millions of visits)
• Figure 3-8: Composition of Chinese Hospital Sector by Number of Beds, 2000-2010 (percent)
• Figure 3-9: Urban China Healthcare Market (Total Consumer/Out-of-Pocket/Insurance Expenditures) (2004-2010) (billion yuan)
• Table 3-4: Urban China Healthcare Market (Total Consumer/Out-of-Pocket/Insurance Expenditures) (2004-2010) (billion yuan)
• Figure 3-10: Top and Bottom Five Provincial Markets for Urban Healthcare by Gain and Loss in National Market Share (2010-2015)
• Figure 3-11: U.S. Medical Product Export Growth to China (1990-2010)
• Figure 3-12: Total U.S.-EU Exports to China - Pharmaceutical Products and Medical Devices (2002-2010) (millions of U.S. dollars)
• Figure 3-13: Inbound Foreign Direct Investment in Medical Product Manufacturing in China (2002-2010)
• Figure 3-14: Foreign-Invested Manufacturing Enterprises in China (1980-2010)
• Figure 3-15: Foreign-Invested Manufacturing Enterprises in China by Province/Municipality (1995-2010)

CHAPTER FOUR: DIAGNOSTICS IN CHINA - MARKET OPPORTUNITIES AND CHALLENGES THROUGH 2015

• Figure 4-1: Chronic Disease Morbidity Rates in Urban China - Hypertension, Diabetes, Cerebrovascular Disease (Stroke), Chronic Obstructive Pulmonary Disease, Heart Disease (per thousand [0/00]) (2003/2008)
• Figure 4-2: Chronic Disease Morbidity Rates in Rural China - Hypertension, Diabetes, Stroke, Chronic Obstructive Pulmonary Disease, Heart Disease (2003/2008)
• Figure 4-3: Cancer Mortality Rates in China - Lung, Liver, Stomach, Esophageal, Colon, Leukemia, Brain, Breast, Pancreatic (Per 100,000) (2005)
• Table 4-1: Incidence Rates for Top Ten Notifiable Infectious Diseases (2010)
• Table 4-2: Selected Preventative Medicine Opportunities
• Table 4-3: Selected Disease Prevention Programs in China's Healthcare Reform (2009-2011)
• Table 4-4: Clinical Labs by Instrumentation Type in BRIC Countries
• Figure 4-4: Chinese Market for IVD Reagents ($ millions) (2004-2015)
• Figure 4-5: Regional Market Divisions for Medical Products in China (Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern)
• Table 4-5: Regional Markets for IVD Products in China (Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern), 2010-2015
• Table 4-6: IVD Market Segmentation (2009) (% of sales)
• Table 4-7: IVD Market Shares by Company (2009) (%)
• Table 4-8: BRIC IVD Market Comparison (2010) ($ millions)
• Table 4-9: Selected Made-in-China Lab Supplies
• Table 4-10: Selected IVD Manufacturers in China
• Figure 4-6: IVD Product Registration and Regulatory Flowchart

CHAPTER FIVE: MEDICAL DEVICES IN CHINA - MARKET OPPORTUNITIES AND CHALLENGES THROUGH 2015

• Figure 5-1: Cancer Mortality Rates in China - Lung, Liver, Stomach, Esophageal, Colon, Leukemia, Brain, Breast, Pancreatic (Per 100,000) (2005)
• Figure 5-2: Chinese Population by Age (Total; 1990/2000/2009) (%)
• Figure 5-3: Composition of Chinese Hospital Sector by Number of Beds, 2000-2010
• Figure 5-4: Compositional Changes in the Hospital Sector - Private, Third-Level and Specialty Hospitals (2005-2010)
• Figure 5-5: Chinese Market for Medical Devices ($ billions) (2004-2015)
• Figure 5-6: Regional Market Divisions for Medical Products in China (Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern)
• Table 5-1: Regional Markets for Medical Devices in China, $ billions 2010 and 2015 (Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern)
• Figure 5-7: China Medical Device Market - Product Segment Shares Percent, 2010 (Surgical Instrument, Disposable, Patient Monitoring, IVD, Imaging, Orthopedic, Other)
• Figure 5-8: Foreign-Invested Manufacturing Enterprises in China (1980-2010)
• Figure 5-9: Medical Device Registration and Approval Flowchart

CHAPTER SIX: PHARMACEUTICALS IN CHINA - MARKET OPPORTUNITIES AND CHALLENGES THROUGH 2015

• Figure 6-1: Chronic Disease Morbidity Rates in Urban China - Hypertension, Diabetes, Cerebrovascular Disease (Stroke), Chronic Obstructive Pulmonary Disease, Heart Disease (per thousand [0/00]) (2003/2008)
• Figure 6-2: Cancer Mortality Rates in China - Lung, Liver, Stomach, Esophageal, Colon, Leukemia, Brain, Breast, Pancreatic (Per 100,000) (2005)
• Table 6-1: Incidence Rates for Top Ten Notifiable Infectious Diseases (2010)
• Figure 6-3: Chinese Market for Pharmaceuticals (incl. Hong Kong) ($ billions) (2004-2015)
• Figure 6-4: Regional Market Divisions for Medical Products in China (Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern)
• Table 6-2: Regional Markets for Pharmaceuticals in China, $ billions, 2010-2015 (Eastern , Northern , Central , Southern , Northeastern , Southwestern , Northwestern )
• Figure 6-5: China Pharmaceutical Market - Patented Prescription, Generics, OTC Market Shares (%) (2010)
• Table 6-3: China Pharmaceutical Market (Patented Prescription and Generics only) by Product Segment, 2010 and 2015 (Cardiovascular, Gastrointestinal, Anti-Infectives, Neurotherapetuics, Oncology, Respiratory, Other)
• Figure 6-6: Foreign-Invested Manufacturing Enterprises in China (1980-2010)
• Table 6-4: Leading Medicinal Manufacturers in China (2009) (%, National Share of Aggregate Pharma/TCM/Nutritional Market)
• Table 6-5: Pharmaceutical Price Cuts (2000-2010)
• Figure 6-7: Pharmaceutical Approval and Regulatory Flowchart

中國準都市醫藥品•醫療機器的市場機會